Results 21 to 30 of about 4,034,895 (347)

MAPK/ERK-CBP-RFPL-3 Mediates Adipose-Derived Stem Cell-Induced Tumor Growth in Breast Cancer Cells by Activating Telomerase Reverse Transcriptase Expression

Stem Cells International, 2022
Adipose-derived stem cells (ASCs) improve the self-renewal and survival of fat grafts in breast reconstruction after oncology surgery. However, ASCs have also been found to enhance breast cancer growth, and its role in tumor proliferation remains largely
Wenjie Li, Cheng Qian, Fei Ma, Meng Liu, Xiaojun Sun, Xu Liu, Chunxiao Liu, Zhenghua Chen, Weichang Ma, Jian Liu, Haiqian Xu, Zhenlin Yang   +11 more
doaj   +1 more source

Breast imaging, breast surgery, and cancer genetics in the age of COVID‐19

Cancer, 2020
The objective of the current study was to provide insight into the effect of coronavirus disease 2019 (COVID‐19) on breast cancer screening, breast surgery, and genetics consultations.
K. Yin, Preeti Singh, B. Drohan, K. Hughes   +3 more
semanticscholar   +1 more source

Chronic Pain Following Cosmetic Breast Surgery: A Comprehensive Review

Pain and Therapy, 2020
Introduction Cosmetic breast surgery is commonly performed in the United States; 520,000 procedures of the total 1.8 million cosmetic surgical procedures performed in 2018 were breast related.
Ivan Urits, C. Lavin, Megha Patel, N. Maganty, Xander Jacobson, Anh L. Ngo, R. Urman, A. Kaye, Omar Viswanath   +8 more
semanticscholar   +1 more source

“An Unusual Pattern of Metastasis” Metastatic Malignant Thymoma Presented with Breast Lump: A Case Report and Literature Review

Case Reports in Surgery, 2023
Metastatic lesions to the breast from extramammary malignant neoplasms are rare and reported account for 0.5–6.6% of all breast malignancies. Distant metastasis of thymoma is even rarer, especially to extrathoracic regions.
Kah-Seng Khoo, Kavinya Diana T. Nadesalingam, Diana Bee-Lan Ong, Li-Ying Teoh, Mei-Sze Teh, Suniza Jamaris, Mee-Hoong See   +6 more
doaj   +1 more source

Usefulness and Prospects of Sentinel Lymph Node Biopsy for Patients With Breast Cancer Using the Medical Imaging Projection System

Frontiers in Oncology, 2021
BackgroundThe Medical Imaging Projection System (MIPS) projects indocyanine green (ICG) fluorescence images directly on the surgical field using a projection mapping technique. We conducted an observational study of sentinel lymph node (SLN) biopsy using
Yuki Nakamura, Masahiro Takada, Michiko Imamura, Akane Higami, He Jiaxi, Makoto Fujino, Rie Nakagawa, Yukiko Inagaki, Yoshiaki Matsumoto, Kosuke Kawaguchi, Masahiro Kawashima, Eiji Suzuki, Masakazu Toi   +12 more
doaj   +1 more source

Application of Fat Grafting in Cosmetic Breast Surgery

Seminars in Plastic Surgery, 2020
The role of fat grafting to the breasts has evolved in the recent past, gaining several new applications within both reconstructive and aesthetic surgery.
Matthew J Davis, A. Perdanasari, Amjed Abu-Ghname, S. Gonzalez, E. Chamata, C. Rammos, Sebastian J. Winocour   +6 more
semanticscholar   +1 more source

Rationale and design of a phase II trial of pyrotinib in combination with nab-paclitaxel as adjuvant therapy for N0/N1mi, HER2 + early breast cancer (PHAEDRA)

BMC Cancer, 2022
Background The de-escalation treatment in patients with low-risk HER2-positive early breast cancer (eBC) is an attractive strategy to avoid unnecessary treatment and improve the quality of life of patients.
Changjun Wang, Yidong Zhou, Yan Lin, Feng Mao, Jinghong Guan, Xiaohui Zhang, Songjie Shen, Xuejing Wang, Yanna Zhang, Bo Pan, Ying Zhong, Li Peng, Xi Cao, Ru Yao, Xingtong Zhou, Chi Xu, Ying Xu, Qiang Sun   +17 more
doaj   +1 more source

Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study

The Breast Journal, 2022
Background. Estrogen and progesterone receptor status can predict breast cancer patient prognosis and treatment sensitivity, but research on low ER and PR levels and expression balance remains limited. Methods.
Jin Liu, Mingyu Gan, Zijing Lin, Qin Deng, Juan Deng, Bin Zeng, Yanling Shi, Jia Ming   +7 more
doaj   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Identification of Genes Predicting Poor Response of Trastuzumab in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

Journal of Immunology Research, 2022
Objective. To identify trastuzumab-resistant genes predicting drug response and poor prognosis in human epidermal growth factor receptor 2 positive (HER2+) breast cancer. Methods.
Xinrui Dong, Huijuan Dai, Aijun Sun, Zhenfeng Yu, Yueyao Du   +4 more
doaj   +1 more source